CD56 identifies natural killer cells, the part of the immune system that kills without needing to be taught what to look for. The same marker appears on neuroendocrine cancers, which is why it is used in diagnosis as well. This dossier gathers the 0 products (0 approved), 0 trials, 0 pathways and 0 resistance routes in the corpus that involve it, with external identifiers so it can be joined to UniProt, ChEMBL, Open Targets and the rest of biology.
Adhesion molecule of the immunoglobulin superfamily; the defining marker of natural killer cells and expressed on neuroendocrine tissue.
No product in the corpus is aimed at this target yet.
No trial in the corpus names this target or one of its products.
No recorded escape route names this target.
No pathway diagram carries this target as a node.
No companion diagnostic in the registry measures this target.
No model entry for this target yet; check the cancer entries on the models page.
No open questions recorded for this target yet. Suggest one.
Query for this target: (TITLE:"CD56" OR ABSTRACT:"CD56" OR TITLE:"NCAM1" OR ABSTRACT:"NCAM1" OR TITLE:"neural cell adhesion molecule 1" OR ABSTRACT:"neural cell adhesion molecule 1") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about CD56, not a curated reading list.
The dossier as machine-readable JSON, at /api/v1/dossiers/cd56.json: identifiers from HGNC, Ensembl, UniProt and ChEMBL, products with status, trials, pathways, hotspots, open questions and assays. The full entity record is in the open API at /api/v1/entities/cd56.json. Licence CC BY-NC 4.0.